Shanghai Guangsheng Biopharmaceutical Co., Ltd

This study is for people with advanced bile duct cancer that has caused a blockage. It tests a new approach: a light-activated drug (sodium porphyrin) given with standard chemotherapy. The goal is to see if this combination can help patients live longer and control the disease be…